{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:16:11Z","timestamp":1762503371834,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_182366"],"award-info":[{"award-number":["320030_182366"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ctro.2023.100611","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T02:04:21Z","timestamp":1678241061000},"page":"100611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function"],"prefix":"10.1016","volume":"40","author":[{"given":"Jennifer","family":"Le Guevelou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9883","authenticated-orcid":false,"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ctro.2023.100611_b0005","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","article-title":"Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions","volume":"25","author":"D'Amico","year":"2007","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100611_b0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3816\/CGC.2008.n.008","article-title":"Quality of life, morbidity, and mortality results of a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen relapse after radiation therapy for locally advanced prostate cancer","volume":"6","author":"Bruchovsky","year":"2008","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ctro.2023.100611_b0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2307\/3574084","article-title":"Effect of graded doses of ionizing radiation on the human testis","volume":"59","author":"Rowley","year":"1974","journal-title":"Radiat Res"},{"issue":"1","key":"10.1016\/j.ctro.2023.100611_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-8140(94)01501-S","article-title":"Leydig cell function and radiation: a review of the literature","volume":"34","author":"Izard","year":"1995","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100611_b0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0360-3016(97)00311-8","article-title":"Serum testosterone levels after external beam radiation for clinically localized prostate cancer","volume":"39","author":"Zagars","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2023.100611_b0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13566-012-0007-1","article-title":"Serum testosterone level after intensity-modulated radiotherapy in low-risk prostate cancer patients: does testicular dose correlate with testosterone level?","volume":"1","author":"Ishiyama","year":"2012","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ctro.2023.100611_b0035","doi-asserted-by":"crossref","unstructured":"Pompe RS, Karakiewicz PI, Zaffuto E, Smith A, Bandini M, Marchioni M, et al. External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate Cancer. J Sex Med 2017;14:876\u201382.","DOI":"10.1016\/j.jsxm.2017.04.675"},{"issue":"6","key":"10.1016\/j.ctro.2023.100611_b0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.prro.2014.02.004","article-title":"Low incidence of new biochemical hypogonadism after intensity modulated radiation therapy for prostate cancer","volume":"4","author":"Markovina","year":"2014","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100611_b0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cncr.10219","article-title":"Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinoma","volume":"94","author":"Pickles","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2023.100611_b0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijrobp.2019.05.014","article-title":"Testosterone levels and sexual quality of life after stereotactic body radiation therapy for prostate cancer: a multi-institutional analysis of prospective trials","volume":"105","author":"Yuan","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2023.100611_b0055","doi-asserted-by":"crossref","unstructured":"Roach M, Nam J, Gagliardi G, El Naqa I, Deasy JO, Marks LB. Radiation dose-volume effects and the penile bulb. Int J Radiat Oncol Biol Phys 2010;76:S130-134.","DOI":"10.1016\/j.ijrobp.2009.04.094"},{"issue":"4","key":"10.1016\/j.ctro.2023.100611_b0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.eururo.2017.02.007","article-title":"Vessel-sparing Radiotherapy for Localized Prostate Cancer to Preserve Erectile Function: A Single-arm Phase 2 Trial","volume":"72","author":"Spratt","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2023.100611_b0065","unstructured":"Teunissen FR. Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment. J Sex Med n.d.:5."},{"key":"10.1016\/j.ctro.2023.100611_b0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phro.2021.09.002","article-title":"Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients","volume":"20","author":"Teunissen","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2023.100611_b0075","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S0022-5347(05)65002-1","article-title":"Members of the British Columbia Cancer Agency Prostate Cohort Outcomes Initiative. What happens to testosterone after prostate radiation monotherapy and does it matter?","volume":"167","author":"Pickles","year":"2002","journal-title":"J Urol"},{"issue":"36","key":"10.1016\/j.ctro.2023.100611_b0080","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1200\/JCO.2009.24.3808","article-title":"To treat pelvic nodes or not: could the greater testicular scatter dose from whole pelvic fields confound results of prostate cancer trials?","volume":"27","author":"King","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2023.100611_b0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2021.04.018","article-title":"Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial","volume":"160","author":"Zapatero","year":"2021","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100611_b0090","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijrobp.2008.09.004","article-title":"Testicular dose from prostate cyberknife: a cautionary note","volume":"73","author":"King","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2023.100611_b0095","article-title":"Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer","volume":"4","author":"Oermann","year":"2011","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.ctro.2023.100611_b0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0022-5347(17)45831-9","article-title":"The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate","volume":"135","author":"Grigsby","year":"1986","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100611_b0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-5347(17)51110-6","article-title":"Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin","volume":"130","author":"Tomi\u0107","year":"1983","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100611_b0110","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ijrobp.2011.01.071","article-title":"Testicular doses in image-guided radiotherapy of prostate cancer","volume":"82","author":"Deng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2023.100611_b0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jmrs.224","article-title":"Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment","volume":"64","author":"Bell","year":"2017","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.ctro.2023.100611_b0120","doi-asserted-by":"crossref","unstructured":"Kishan AU, Ma TM, Lamb JM, Casado M, Wilhalme H, Low DA, et al. Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial. JAMA Oncol 2023.","DOI":"10.1001\/jamaoncol.2022.6558"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:12:11Z","timestamp":1762503131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":24,"alternative-id":["S2405630823000368"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100611","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100611"}}